title: Prolonged remission of HIV-associated multicentric Castelman's disease with an anti-CD20 monoclonal antibody as primary therapy.
authors.forename: Frédéric
authors.initials: F
authors.lastname: Marrache
authors.forename: Claire
authors.initials: C
authors.lastname: Larroche
authors.forename: Nathalie
authors.initials: N
authors.lastname: Mémain
authors.forename: Olivier
authors.initials: O
authors.lastname: Bouchaud
authors.forename: Michel
authors.initials: M
authors.lastname: Robineau
authors.forename: Olivier
authors.initials: O
authors.lastname: Hermine
authors.forename: Olivier
authors.initials: O
authors.lastname: Lortholary
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000276:immunology*; D000998:Antiviral Agents / Q000627:therapeutic use*; D005871:Castleman Disease / Q000628:therapy*; D015658:HIV Infections / Q000628:therapy*; D006801:Humans; D008297:Male; D012074:Remission Induction / Q000379:methods; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000998:Antiviral Agents; D000069283:Rituximab